Industry Research Reports
Global Varicella Vaccine Market Insights, Forecast to 2030
Industry: Pharma & Healthcare
Published Date: 2024-04-07
Pages: 87 Pages
Report ld: 2713864
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Varicella Vaccine Market Size(US$)
CAGR 2024-2030
7.8%
Market Size,2030
USD 7,104.7
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 4,527.3 million
Market Forecast in 2030(Value)
US$ 7,104.7 million
CAGR
7.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
The global Varicella Vaccine market is projected to grow from US$ 4527.3 million in 2024 to US$ 7104.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
Report Covers:
This report presents an overview of global market for Varicella Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Varicella Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Varicella Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Varicella Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Varicella Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Varicella Vaccine sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Merck
- GSK
- Shanghai Institute
- BCHT
- Changsheng
- Keygen
- Green Cross
- Biken
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Injection
- Freeze-Dried Powder
Segment by Application
- Kids Injection
- Adults Injection
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Varicella Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Varicella Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Varicella Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Varicella Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Market by Application
1.3.1 Global Varicella Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Varicella Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global Varicella Vaccine Revenue by Region
2.2.1 Global Varicella Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Varicella Vaccine Revenue by Region (2019-2024)
2.2.3 Global Varicella Vaccine Revenue by Region (2025-2030)
2.2.4 Global Varicella Vaccine Revenue Market Share by Region (2019-2030)
2.3 Global Varicella Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global Varicella Vaccine Sales by Region
2.4.1 Global Varicella Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Varicella Vaccine Sales by Region (2019-2024)
2.4.3 Global Varicella Vaccine Sales by Region (2025-2030)
2.4.4 Global Varicella Vaccine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Varicella Vaccine Sales by Manufacturers
3.1.1 Global Varicella Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global Varicella Vaccine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Varicella Vaccine in 2023
3.2 Global Varicella Vaccine Revenue by Manufacturers
3.2.1 Global Varicella Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global Varicella Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Varicella Vaccine Revenue in 2023
3.3 Global Key Players of Varicella Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Varicella Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Varicella Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Varicella Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Varicella Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Varicella Vaccine Sales by Type
4.1.1 Global Varicella Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global Varicella Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global Varicella Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Varicella Vaccine Revenue by Type
4.2.1 Global Varicella Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global Varicella Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Varicella Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Varicella Vaccine Price by Type
4.3.1 Global Varicella Vaccine Price by Type (2019-2024)
4.3.2 Global Varicella Vaccine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Varicella Vaccine Sales by Application
5.1.1 Global Varicella Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global Varicella Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global Varicella Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Varicella Vaccine Revenue by Application
5.2.1 Global Varicella Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global Varicella Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Varicella Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Varicella Vaccine Price by Application
5.3.1 Global Varicella Vaccine Price by Application (2019-2024)
5.3.2 Global Varicella Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Varicella Vaccine Market Size by Type
6.1.1 US & Canada Varicella Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada Varicella Vaccine Revenue by Type (2019-2030)
6.2 US & Canada Varicella Vaccine Market Size by Application
6.2.1 US & Canada Varicella Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada Varicella Vaccine Revenue by Application (2019-2030)
6.3 US & Canada Varicella Vaccine Market Size by Country
6.3.1 US & Canada Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Varicella Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada Varicella Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Varicella Vaccine Market Size by Type
7.1.1 Europe Varicella Vaccine Sales by Type (2019-2030)
7.1.2 Europe Varicella Vaccine Revenue by Type (2019-2030)
7.2 Europe Varicella Vaccine Market Size by Application
7.2.1 Europe Varicella Vaccine Sales by Application (2019-2030)
7.2.2 Europe Varicella Vaccine Revenue by Application (2019-2030)
7.3 Europe Varicella Vaccine Market Size by Country
7.3.1 Europe Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Varicella Vaccine Sales by Country (2019-2030)
7.3.3 Europe Varicella Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Varicella Vaccine Market Size
8.1.1 China Varicella Vaccine Sales (2019-2030)
8.1.2 China Varicella Vaccine Revenue (2019-2030)
8.2 China Varicella Vaccine Market Size by Application
8.2.1 China Varicella Vaccine Sales by Application (2019-2030)
8.2.2 China Varicella Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Varicella Vaccine Market Size by Type
9.1.1 Asia Varicella Vaccine Sales by Type (2019-2030)
9.1.2 Asia Varicella Vaccine Revenue by Type (2019-2030)
9.2 Asia Varicella Vaccine Market Size by Application
9.2.1 Asia Varicella Vaccine Sales by Application (2019-2030)
9.2.2 Asia Varicella Vaccine Revenue by Application (2019-2030)
9.3 Asia Varicella Vaccine Sales by Region
9.3.1 Asia Varicella Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Varicella Vaccine Revenue by Region (2019-2030)
9.3.3 Asia Varicella Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Varicella Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Varicella Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Varicella Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Varicella Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Varicella Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Varicella Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Varicella Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Varicella Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Varicella Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Varicella Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 GSK Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Shanghai Institute
11.3.1 Shanghai Institute Company Information
11.3.2 Shanghai Institute Overview
11.3.3 Shanghai Institute Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Shanghai Institute Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shanghai Institute Recent Developments
11.4 BCHT
11.4.1 BCHT Company Information
11.4.2 BCHT Overview
11.4.3 BCHT Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 BCHT Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BCHT Recent Developments
11.5 Changsheng
11.5.1 Changsheng Company Information
11.5.2 Changsheng Overview
11.5.3 Changsheng Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Changsheng Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Changsheng Recent Developments
11.6 Keygen
11.6.1 Keygen Company Information
11.6.2 Keygen Overview
11.6.3 Keygen Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Keygen Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Keygen Recent Developments
11.7 Green Cross
11.7.1 Green Cross Company Information
11.7.2 Green Cross Overview
11.7.3 Green Cross Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Green Cross Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Green Cross Recent Developments
11.8 Biken
11.8.1 Biken Company Information
11.8.2 Biken Overview
11.8.3 Biken Varicella Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Biken Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biken Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Varicella Vaccine Industry Chain Analysis
12.2 Varicella Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Varicella Vaccine Production Mode & Process
12.4 Varicella Vaccine Sales and Marketing
12.4.1 Varicella Vaccine Sales Channels
12.4.2 Varicella Vaccine Distributors
12.5 Varicella Vaccine Customers
13 Market Dynamics
13.1 Varicella Vaccine Industry Trends
13.2 Varicella Vaccine Market Drivers
13.3 Varicella Vaccine Market Challenges
13.4 Varicella Vaccine Market Restraints
14 Key Findings in The Global Varicella Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Varicella Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Freeze-Dried Powder
Table 4. Global Varicella Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Varicella Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Varicella Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Varicella Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Varicella Vaccine Revenue Market Share by Region (2019-2024)
Table 9. Global Varicella Vaccine Revenue Market Share by Region (2025-2030)
Table 10. Global Varicella Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Varicella Vaccine Sales by Region (2019-2024) & (M Doses)
Table 12. Global Varicella Vaccine Sales by Region (2025-2030) & (M Doses)
Table 13. Global Varicella Vaccine Sales Market Share by Region (2019-2024)
Table 14. Global Varicella Vaccine Sales Market Share by Region (2025-2030)
Table 15. Global Varicella Vaccine Sales by Manufacturers (2019-2024) & (M Doses)
Table 16. Global Varicella Vaccine Sales Share by Manufacturers (2019-2024)
Table 17. Global Varicella Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Varicella Vaccine Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Varicella Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Varicella Vaccine Price by Manufacturers 2019-2024 (USD/Dose)
Table 21. Global Varicella Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Varicella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varicella Vaccine as of 2023)
Table 23. Global Key Manufacturers of Varicella Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Varicella Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Varicella Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 28. Global Varicella Vaccine Sales by Type (2025-2030) & (M Doses)
Table 29. Global Varicella Vaccine Sales Share by Type (2019-2024)
Table 30. Global Varicella Vaccine Sales Share by Type (2025-2030)
Table 31. Global Varicella Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Varicella Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Varicella Vaccine Revenue Share by Type (2019-2024)
Table 34. Global Varicella Vaccine Revenue Share by Type (2025-2030)
Table 35. Varicella Vaccine Price by Type (2019-2024) & (USD/Dose)
Table 36. Global Varicella Vaccine Price Forecast by Type (2025-2030) & (USD/Dose)
Table 37. Global Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 38. Global Varicella Vaccine Sales by Application (2025-2030) & (M Doses)
Table 39. Global Varicella Vaccine Sales Share by Application (2019-2024)
Table 40. Global Varicella Vaccine Sales Share by Application (2025-2030)
Table 41. Global Varicella Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Varicella Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Varicella Vaccine Revenue Share by Application (2019-2024)
Table 44. Global Varicella Vaccine Revenue Share by Application (2025-2030)
Table 45. Varicella Vaccine Price by Application (2019-2024) & (USD/Dose)
Table 46. Global Varicella Vaccine Price Forecast by Application (2025-2030) & (USD/Dose)
Table 47. US & Canada Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 48. US & Canada Varicella Vaccine Sales by Type (2025-2030) & (M Doses)
Table 49. US & Canada Varicella Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Varicella Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. US & Canada Varicella Vaccine Sales by Application (2025-2030) & (M Doses)
Table 53. US & Canada Varicella Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Varicella Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Varicella Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 59. US & Canada Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 60. Europe Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 61. Europe Varicella Vaccine Sales by Type (2025-2030) & (M Doses)
Table 62. Europe Varicella Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Varicella Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 65. Europe Varicella Vaccine Sales by Application (2025-2030) & (M Doses)
Table 66. Europe Varicella Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Varicella Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Varicella Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 72. Europe Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 73. China Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 74. China Varicella Vaccine Sales by Type (2025-2030) & (M Doses)
Table 75. China Varicella Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Varicella Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 78. China Varicella Vaccine Sales by Application (2025-2030) & (M Doses)
Table 79. China Varicella Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Varicella Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 82. Asia Varicella Vaccine Sales by Type (2025-2030) & (M Doses)
Table 83. Asia Varicella Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Varicella Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 86. Asia Varicella Vaccine Sales by Application (2025-2030) & (M Doses)
Table 87. Asia Varicella Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Varicella Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Varicella Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Varicella Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Varicella Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Varicella Vaccine Sales by Region (2019-2024) & (M Doses)
Table 93. Asia Varicella Vaccine Sales by Region (2025-2030) & (M Doses)
Table 94. Middle East, Africa and Latin America Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 95. Middle East, Africa and Latin America Varicella Vaccine Sales by Type (2025-2030) & (M Doses)
Table 96. Middle East, Africa and Latin America Varicella Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Varicella Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 99. Middle East, Africa and Latin America Varicella Vaccine Sales by Application (2025-2030) & (M Doses)
Table 100. Middle East, Africa and Latin America Varicella Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Varicella Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Varicella Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 106. Middle East, Africa and Latin America Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 110. Merck Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 115. GSK Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Shanghai Institute Company Information
Table 118. Shanghai Institute Description and Major Businesses
Table 119. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 120. Shanghai Institute Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Shanghai Institute Recent Developments
Table 122. BCHT Company Information
Table 123. BCHT Description and Major Businesses
Table 124. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 125. BCHT Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. BCHT Recent Developments
Table 127. Changsheng Company Information
Table 128. Changsheng Description and Major Businesses
Table 129. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 130. Changsheng Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Changsheng Recent Developments
Table 132. Keygen Company Information
Table 133. Keygen Description and Major Businesses
Table 134. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 135. Keygen Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Keygen Recent Developments
Table 137. Green Cross Company Information
Table 138. Green Cross Description and Major Businesses
Table 139. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 140. Green Cross Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Green Cross Recent Developments
Table 142. Biken Company Information
Table 143. Biken Description and Major Businesses
Table 144. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 145. Biken Varicella Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Biken Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Varicella Vaccine Distributors List
Table 150. Varicella Vaccine Customers List
Table 151. Varicella Vaccine Market Trends
Table 152. Varicella Vaccine Market Drivers
Table 153. Varicella Vaccine Market Challenges
Table 154. Varicella Vaccine Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Varicella Vaccine Product Picture
Figure 2. Global Varicella Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Varicella Vaccine Market Share by Type in 2023 & 2030
Figure 4. Injection Product Picture
Figure 5. Freeze-Dried Powder Product Picture
Figure 6. Global Varicella Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Varicella Vaccine Market Share by Application in 2023 & 2030
Figure 8. Kids Injection
Figure 9. Adults Injection
Figure 10. Varicella Vaccine Report Years Considered
Figure 11. Global Varicella Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Varicella Vaccine Revenue 2019-2030 (US$ Million)
Figure 13. Global Varicella Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Varicella Vaccine Revenue Market Share by Region (2019-2030)
Figure 15. Global Varicella Vaccine Sales 2019-2030 ((M Doses)
Figure 16. Global Varicella Vaccine Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Varicella Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 18. US & Canada Varicella Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Varicella Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 20. Europe Varicella Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Varicella Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 22. China Varicella Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Varicella Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 24. Asia (excluding China) Varicella Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Varicella Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 26. Middle East, Africa and Latin America Varicella Vaccine Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Varicella Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Varicella Vaccine in the World: Market Share by Varicella Vaccine Revenue in 2023
Figure 29. Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Varicella Vaccine Sales Market Share by Type (2019-2030)
Figure 31. Global Varicella Vaccine Revenue Market Share by Type (2019-2030)
Figure 32. Global Varicella Vaccine Sales Market Share by Application (2019-2030)
Figure 33. Global Varicella Vaccine Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Varicella Vaccine Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Varicella Vaccine Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Varicella Vaccine Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Varicella Vaccine Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Varicella Vaccine Revenue Share by Country (2019-2030)
Figure 39. US & Canada Varicella Vaccine Sales Share by Country (2019-2030)
Figure 40. U.S. Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Varicella Vaccine Sales Market Share by Type (2019-2030)
Figure 43. Europe Varicella Vaccine Revenue Market Share by Type (2019-2030)
Figure 44. Europe Varicella Vaccine Sales Market Share by Application (2019-2030)
Figure 45. Europe Varicella Vaccine Revenue Market Share by Application (2019-2030)
Figure 46. Europe Varicella Vaccine Revenue Share by Country (2019-2030)
Figure 47. Europe Varicella Vaccine Sales Share by Country (2019-2030)
Figure 48. Germany Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 49. France Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. China Varicella Vaccine Sales Market Share by Type (2019-2030)
Figure 54. China Varicella Vaccine Revenue Market Share by Type (2019-2030)
Figure 55. China Varicella Vaccine Sales Market Share by Application (2019-2030)
Figure 56. China Varicella Vaccine Revenue Market Share by Application (2019-2030)
Figure 57. Asia Varicella Vaccine Sales Market Share by Type (2019-2030)
Figure 58. Asia Varicella Vaccine Revenue Market Share by Type (2019-2030)
Figure 59. Asia Varicella Vaccine Sales Market Share by Application (2019-2030)
Figure 60. Asia Varicella Vaccine Revenue Market Share by Application (2019-2030)
Figure 61. Asia Varicella Vaccine Revenue Share by Region (2019-2030)
Figure 62. Asia Varicella Vaccine Sales Share by Region (2019-2030)
Figure 63. Japan Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 67. India Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Varicella Vaccine Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Varicella Vaccine Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Varicella Vaccine Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Varicella Vaccine Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Varicella Vaccine Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Varicella Vaccine Sales Share by Country (2019-2030)
Figure 74. Brazil Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Varicella Vaccine Revenue (2019-2030) & (US$ Million)
Figure 79. Varicella Vaccine Value Chain
Figure 80. Varicella Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Varicella Vaccine in 2030?
The global market size of Varicella Vaccine in 2030 was 7104.7 Million USD.
What is the annual compound growth rate of the global Varicella Vaccine market size from 2024 to 2030?
Which companies rank high in the global Varicella Vaccine market?
Which region is expected to have the highest market share?
What was the global market size of Varicella Vaccine in 2024?
Related Reports
Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Varicella Vaccine market size was US$ 5185 million in 2025 and is forecast to reach a readjusted size of US$ 8708 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 79
USD 4250.00
(Single User License)
Global Varicella Vaccine Market Research Report 2026
The global Varicella Vaccine market was valued at US$ 5185 million in 2025 and is anticipated to reach US$ 8708 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 114
USD 2900.00
(Single User License)
Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Varicella Vaccine was estimated to be worth US$ 5185 million in 2025 and is projected to reach US$ 8708 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 96
USD 3950.00
(Single User License)
Global Varicella Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Varicella Vaccine market is projected to grow from US$ 4845 million in 2024 to US$ 8137 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 149
USD 4900.00
(Single User License)
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Varicella Vaccine was estimated to be worth US$ 4845 million and is forecast to reach approximately US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 135
USD 5900.00
(Single User License)
Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Varicella Vaccine market size was US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 77
USD 4250.00
(Single User License)
Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Varicella Vaccine was estimated to be worth US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Varicella Vaccine Market Research Report 2025
The global market for Varicella Vaccine was valued at US$ 4845 million in the year 2024 and is projected to reach a revised size of US$ 8137 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-01-16
Pages: 80
USD 2900.00
(Single User License)
Global Varicella Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published Date: 2024-04-17
Pages: 140
USD 5600.00
(Single User License)
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published Date: 2024-04-16
Pages: 130
USD 5900.00
(Single User License)
Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Varicella Vaccine market size was US$ 5185 million in 2025 and is forecast to reach a readjusted size of US$ 8708 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 79
USD 4250.00 (Single User License)Global Varicella Vaccine Market Research Report 2026
The global Varicella Vaccine market was valued at US$ 5185 million in 2025 and is anticipated to reach US$ 8708 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 114
USD 2900.00 (Single User License)Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Varicella Vaccine was estimated to be worth US$ 5185 million in 2025 and is projected to reach US$ 8708 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 96
USD 3950.00 (Single User License)Global Varicella Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Varicella Vaccine market is projected to grow from US$ 4845 million in 2024 to US$ 8137 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 149
USD 4900.00 (Single User License)Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Varicella Vaccine was estimated to be worth US$ 4845 million and is forecast to reach approximately US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 135
USD 5900.00 (Single User License)Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Varicella Vaccine market size was US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 77
USD 4250.00 (Single User License)Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Varicella Vaccine was estimated to be worth US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)Global Varicella Vaccine Market Research Report 2025
The global market for Varicella Vaccine was valued at US$ 4845 million in the year 2024 and is projected to reach a revised size of US$ 8137 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-01-16
Pages: 80
USD 2900.00 (Single User License)Global Varicella Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published: 2024-04-17
Pages: 140
USD 5600.00 (Single User License)Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published: 2024-04-16
Pages: 130
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now